Detection of very early oral cancers in Puerto Rico

American Journal of Public Health

Volumn 98, Issue 7, 2008, Pages 1200-1202

  Morse, Douglas E ^a   Psoter, Walter J ^a   Feliciano, Taína De La Torre ^b   Cruz, Gustavo ^a   Figueroa, Nayda ^b  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b Puerto Rico Central Cancer Registry   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CARCINOMA IN SITU; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PUERTO RICO; UNITED STATES; ADULT; AGED; COMPARATIVE STUDY; EARLY DIAGNOSIS; HEALTH; HEALTH CARE DELIVERY; HEALTH STATUS; MASS SCREENING; MIDDLE AGED; MOUTH TUMOR; PREVALENCE; RISK ASSESSMENT; STATISTICS;

ADULT; AGED; EARLY DIAGNOSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MOUTH NEOPLASMS; ORAL HEALTH; PREVALENCE; PUERTO RICO; RISK ASSESSMENT; UNITED STATES;

EID: 45549105489     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.118679     Document Type: Article

References (15)

1. Melrose RJ. Premalignant oral mucosal diseases. J Calif Dent Assoc. 2001;29:593-600.
2. Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharynx. In: Cancer Epidemiology and Prevention. 3rd ed. Schottenfeld D, Fraumeni JF Jr, eds. Oxford, England: Oxford University Press; 2006:674-696.
3. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer. 1984;53:563-568.
4. Waldron CA, Shafer WG. Leukoplakia revisited. a clinicopathologic study 3256 oral leukoplakias. Cancer. 1975;36:1386-1392.
5. Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer. 1975;36:1021-1028.
6. Lee JJ, Hung HC, Cheng SJ, et al. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:472-480.
7. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52:195-215.
8. Sciubba JJ. Oral cancer and its detection: history-taking and the diagnostic phase of management. J Am Dent Assoc. 2001;132(suppl):12S-18S.
9. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, Version 2.0. Lyon, France: IARC Press; 2004.
10. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
11. Puerto Rican Central Cancer Registry. Preliminary Public-Use Data, Oral Cavity & Pharynx (1987-2001). San Juan: Registro Central de Cáncer de Puerto Rico; 2006.
12. Surveillance, Epidemiology, and End Results (SEER) Program. Public-Use Database (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.
13. Morse DE, Kerr AR. Disparities in oral and pharyngeal cancer incidence, mortality and survival among Black and White Americans. J Am Dent Assoc. 2006;137:203-212.
14. Ord RA, Blanchaert RH Jr. Current management of oral cancer: a multidisciplinary approach. J Am Dent Assoc. 2001;132(suppl):19S-23S.
15. Chandu A, Smith AC, Rogers SN. Health-related quality of life in oral cancer: a review. J Oral Maxillofac Surg. 2006;64:495-502.